Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17261422 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
Condition: Anemia
Intervention: Drug: epoetin beta [NeoRecormon]

Indicates status has not been verified in more than two years